[1] Marx J. How cells cycle towards cancer. Science. 1994,263:319-321. [2] Okamoto A, Reedy EP. Cell cyclins control in mammalian cell:role of cyclins, CDK4 and CKIs. PNAS USA, 1994,91:11045-11052. [3] Krajewska M, Krajewski S, Epstein JI, et al. Immunohistochemical analysis of bcl-2, bax, bcl-Xl, and mcl-1 expression in prostate cancers. Am J Pathol, 1996,148:1567-1576. [4] Mate JL, Ariza A, Roca X, et al. Expression patterns of cyclins D1 and E in condyloma acuminatum in comparison with psoriatic proli ferative lesions. J Pathol, 1998,184:83-88. [5] Jones DL, Munger K. Analysis of the p53 mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol, 1997,71:2905-2912. [6] Berezutskaya E, Bagchi C. The human papillomavirus E7 oncoprotein functionally interacts with S4 subunit of the 26S proteasome. J Biol Chem, 1997,272:30153-30140. [7] Gage JR, Meyers C, Wettstein FO. The E7 proteins of the nonocogenic human papillomavirus type 6b (HPV-6b), and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol, 1990,64:723-730. [8] Yeager T, Stadler W, Belair C, et al, Increased p16 levels correlate with pRb alteration in human urothelial cells. Cancer Res, 1995,55:493-497. [9] Martin LG, Demers GW, Galloway DA. Disruption of the G1/S transition in human papillomavirus type 16 E7 expressing human cells in associated with altered regulation of cyclin E. J Virol, 1998,72:975-985. [10] Shiozama T, Nikaido T, Shimizu M, et al. Immunohistochemical analysis of the expression of CDK4 and p16INK4 in human endometrioid type endometrial carcinoma. Cancer, 1997,80:2250-2256. |